abstract |
The invention relates to compounds of the formula wherein the substituents are as defined in the specification or to a pharmaceutically acceptable salt thereof. The compounds are inhibitors of cysteine proteases, in particular cathepsin K, and are used to treat diseases in which inhibition of bone loss is important. |